‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Während die Studie mit bisher grösster Kohorte zum Ergebnis kommt, dass 89% der PC Betr. #PEM zeigen (n=3762) #FindeDenFehler https://t.co/FPWYPzSdpX
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jul 2021 – Aug 2025Where it's discussed
-
News611 articles
-
X / Twitter231 posts
-
Blogs50 articles
-
Facebook8 posts
-
Reddit5 posts
-
YouTube3 videos
AI synopsis
What people are saying
This collection reflects a strong consensus on the importance of the research, exemplified by comments praising the study as comprehensive and pivotal, while interest is driven by detailed symptom reports like fatigue and cognitive issues, and engagement is evidenced by participants referencing specific articles and data. Overall, the discussions suggest that the publication has a notable influence on ongoing research and public understanding of long COVID.
Most discussions acknowledge the significance of the research and support its findings, with some expressing trust or validation, such as mentions of the study being a major promoter of Long COVID awareness or referencing established researchers.
Given the repeated references and in-depth mentions of symptoms, research details, and implications, there's a high level of interest in understanding the subject, especially with phrases like 'important', 'crucial', and detailed symptom lists.
Many posts engage actively by citing specific studies, sharing examples of symptoms, and discussing implications, which indicates a deep level of engagement rather than superficial mentions.
The discussions reflect the recognition that the study has meaningful implications for understanding long COVID, with mentions of its importance for 2022 and references to its influence on research and public awareness, although some skepticism and histor
Abstract in brief
- This study surveyed over 3700 COVID-19 patients from around the world experiencing long-lasting symptoms (long COVID) for more than 28 days, mainly focusing on outpatient experiences, symptom patterns, and recovery timelines.
- Participants reported an average of 5-6 symptoms affecting multiple organ systems over seven months, with fatigue, postexertional malaise, and cognitive issues being most common even after six months, and many experiencing relapses typically triggered by activity or stress.
- The findings show that most people took over 35 weeks to recover, experienced ongoing symptoms and relapses, and significant impacts on daily life and work, with many needing to reduce work hours or pause normal routines.]
Top posts
Most liked on X and BlueskyHere is the study Balvi Cites, it is a major promotor of Long COVID. I urge you to have a look at the “symptoms” they have listed here: https://t.co/CAJnt5QMOq It’s basically anything and everything that can be considered a symptom to human beings so that narrows it down. It https://t.co/bUKTUATX64
Dos 3.762 entrevistados em um estudo on-line de pessoas com sintomas persistentes após documentado ou suspeito de COVID-19, muitos apresentavam sintomas contínuos até 7 meses após a infecção inicial, incluindo síndromes neuropsiquiátricas proeminentes https://t.co/APJEUNCyG7
@amyboylanwrites Hannah Davis et al paper characterising Long Covid symptoms, found 89% of respondents had PEM https://t.co/sU0FxYESvx
18/ And historic work by so many patients, including: How and Why Patients made Long COVID by @elisaperego78 & @felicitycallard https://t.co/wdXlBK6TcI Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/DAk0WjHhwS
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact: average of 55.9+/- 25.5 symptoms, across average of 9.1 organ systems. most frequent symptoms after 6mth were fatigue,post-exertional malaise,cognitive dysfunction https://t.co/0vIRW4GzPX
All mentions
Understanding Long COVID Brain Fog Fatigue and Mental Health Challenges
This video explores the experiences of long COVID patients, highlighting symptoms like brain fog, fatigue, and mental health issues, as well as the challenges faced in accessing healthcare and the need for improved…
Understanding Long COVID: Persistent Symptoms and Their Impacts
This video introduces the topic of long-term effects of COVID-19, focusing on persistent symptoms that affect the nervous system. It highlights biological factors contributing to diverse symptoms, emphasizing the need…
Understanding Long COVID: Symptoms, Duration, and Impact
Long COVID involves persistent symptoms after COVID-19 infection, often lasting over 7 months. This study of over 3700 patients highlights ongoing fatigue, cognitive issues, relapses, and the significant impact on daily…
RT @ygjumi: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/0xY3BokNyg https://t.…
RT @ygjumi: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact - eClinicalMedicine https://t.co/zM…
RT @ygjumi: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact - eClinicalMedicine https://t.co/zM…
RT @LazarusLong13: @CounsellingSam @surf4children I'll jump in here. I believe we all know the eponymous study on LongCovid with. 220+ sym…
@CounsellingSam @surf4children I'll jump in here. I believe we all know the eponymous study on LongCovid with. 220+ symptoms. Full list appendix A. https://t.co/ki8C4l6Itl Stroke is there. https://t.co/KvVzAxekfL I am leery of removing symptoms as reported by LongHaulers themselves. Particularly, /1
RT @ygjumi: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/0xY3BokNyg https://t.…
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/0xY3BokNyg https://t.co/dYhRKByRW9
RT @ygjumi: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact - eClinicalMedicine https://t.co/zM…
RT @ygjumi: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/zMaLF38lHO
RT @ygjumi: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/0xY3BokfII
RT @ygjumi: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact - eClinicalMedicine https://t.co/zM…
RT @ygjumi: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact - eClinicalMedicine https://t.co/zM…
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact - eClinicalMedicine https://t.co/zMaLF38lHO
@Eerrnn @HarryBoby4 I think this is the source: Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact https://t.co/jQoyuolxHg
RT @JoshWalkos: Here is the study Balvi Cites, it is a major promotor of Long COVID. I urge you to have a look at the “symptoms” they have…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
@aerztezeitung https://t.co/yyaObXWukr
@Karl_Lauterbach @BMG_Bund https://t.co/yyaObXWukr
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
RT @RSandra266: ‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Wäh…
‼️#AusGründen @Karl_Lauterbach twittert interessiert Studie wonach gezielte Belastung bei #PostCovid helfe (n= 31). Während die Studie mit bisher grösster Kohorte zum Ergebnis kommt, dass 89% der PC Betr. #PEM zeigen (n=3762) #FindeDenFehler https://t.co/FPWYPzSdpX
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact - eClinicalMedicine https://t.co/xGdGzZNIZz
RT @AndrewW66619812: The paper in "eClinicalMedicine" the above "Nature" article is based upon, & links to: “Characterizing long COVID in…
The paper in "eClinicalMedicine" the above "Nature" article is based upon, & links to: “Characterizing long COVID in an international cohort: 7 months of symptoms and their impact” 2/2 https://t.co/kSFfGBzCdM
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact - eClinicalMedicine https://t.co/ooBwsmOwlc This reports #LongCovid cases 2019-20 pre #vaccine @ABridgen #antivaxx
RT @ErinSandersNP: 18/ And historic work by so many patients, including: How and Why Patients made Long COVID by @elisaperego78 & @felici…
RT @TactNowInfo: @JoeOlvey @BlueSky_Report Long Covid was well documented before vaccines were available. Understand what's happening and…
@VigilantFox @P_McCulloughMD FYI: Long Covid was well documented before vaccines were available. Understand what's happening and hopefully help avoid a similar situation yourself or to those you care about. Every infection increases risks. "Characterizing long COVID in an international cohort: 7 months of
@Rottielover10 Long Covid was well documented before vaccines were available. Understand what's happening and hopefully help avoid a similar situation yourself or to those you care about. Every infection increases risks. "Characterizing long COVID in an international cohort: 7 months of
@JoeOlvey @BlueSky_Report Long Covid was well documented before vaccines were available. Understand what's happening and hopefully help avoid a similar situation yourself or to those you care about. Every infection increases risks. "Characterizing long COVID in an international cohort: 7 months of
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact - eClinicalMedicine https://t.co/ooBwsmOwlc for info @scam_demic @Telegraph #TalkTV @ME/CFS #COVID-19
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact - eClinicalMedicine https://t.co/ooBwsmOwlc this data was collected pre #vaccine @SpiritualFixed
RT @ygjumi: 国際的コホートにおけるLong COVIDの特性 7ヶ月の症状とその影響 Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impa…
RT @ygjumi: 国際コホートにおける #LongCovid Dの特徴:7か月の症状とその影響 Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Im…
Study: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact The most frequent symptoms after month 6 were fatigue, post-exertional malaise, and cognitive dysfunction. https://t.co/8MJFkO1Gyb
RT @JoshWalkos: Here is the study Balvi Cites, it is a major promotor of Long COVID. I urge you to have a look at the “symptoms” they have…
RT @JoshWalkos: Here is the study Balvi Cites, it is a major promotor of Long COVID. I urge you to have a look at the “symptoms” they have…
RT @JoshWalkos: Here is the study Balvi Cites, it is a major promotor of Long COVID. I urge you to have a look at the “symptoms” they have…
RT @JoshWalkos: Here is the study Balvi Cites, it is a major promotor of Long COVID. I urge you to have a look at the “symptoms” they have…
RT @JoshWalkos: Here is the study Balvi Cites, it is a major promotor of Long COVID. I urge you to have a look at the “symptoms” they have…
RT @JoshWalkos: Here is the study Balvi Cites, it is a major promotor of Long COVID. I urge you to have a look at the “symptoms” they have…
RT @JoshWalkos: Here is the study Balvi Cites, it is a major promotor of Long COVID. I urge you to have a look at the “symptoms” they have…
RT @AthenaAkrami: And here is the preprint: "Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact"…
RT @JoshWalkos: Here is the study Balvi Cites, it is a major promotor of Long COVID. I urge you to have a look at the “symptoms” they have…
RT @JoshWalkos: Here is the study Balvi Cites, it is a major promotor of Long COVID. I urge you to have a look at the “symptoms” they have…
RT @JoshWalkos: Here is the study Balvi Cites, it is a major promotor of Long COVID. I urge you to have a look at the “symptoms” they have…
RT @JoshWalkos: Here is the study Balvi Cites, it is a major promotor of Long COVID. I urge you to have a look at the “symptoms” they have…
RT @JoshWalkos: Here is the study Balvi Cites, it is a major promotor of Long COVID. I urge you to have a look at the “symptoms” they have…
RT @JoshWalkos: Here is the study Balvi Cites, it is a major promotor of Long COVID. I urge you to have a look at the “symptoms” they have…
RT @JoshWalkos: Here is the study Balvi Cites, it is a major promotor of Long COVID. I urge you to have a look at the “symptoms” they have…
Here is the study Balvi Cites, it is a major promotor of Long COVID. I urge you to have a look at the “symptoms” they have listed here: https://t.co/CAJnt5QMOq It’s basically anything and everything that can be considered a symptom to human beings so that narrows it down. It https://t.co/bUKTUATX64
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/puOrYQSobY via @ahandvanish et al
RT @AngelaReiersen: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact - eClinicalMedicine https:/…
RT @AngelaReiersen: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact - eClinicalMedicine https:/…
RT @AngelaReiersen: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact - eClinicalMedicine https:/…
RT @AngelaReiersen: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact - eClinicalMedicine https:/…
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact - eClinicalMedicine https://t.co/1xPqimyCbk
RT @ygjumi: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/zMaLF38lHO
RT @ygjumi: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/zMaLF38lHO
@JTylerHagen @oldfshndanne Clicking on the word "study" in the second line (first sentence) will carry one to: • Characterizing Long COVID in An International Cohort: 7 Months of Symptoms & Their Impact • medRxiv • December 27, 2020 • https://t.co/JXr0GJa9uw
To illustrate this point, at one extreme, we have studies targeted at social media long-Covid focus groups that led to essentially everyone being deemed to be affected by long-Covid, like the 'gem' below. 9/ https://t.co/0WBZbEqisc
RT @BagaiDr: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact: average of 55.9+/- 25.5 symptoms,…
RT @BagaiDr: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact: average of 55.9+/- 25.5 symptoms,…
RT @BagaiDr: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact: average of 55.9+/- 25.5 symptoms,…
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/Ux2VxpGXgD
RT @BagaiDr: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact: average of 55.9+/- 25.5 symptoms,…
RT @BagaiDr: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact: average of 55.9+/- 25.5 symptoms,…
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact 25 July 2021
RT @BagaiDr: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact: average of 55.9+/- 25.5 symptoms,…
RT @BagaiDr: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact: average of 55.9+/- 25.5 symptoms,…
RT @BagaiDr: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact: average of 55.9+/- 25.5 symptoms,…
RT @BagaiDr: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact: average of 55.9+/- 25.5 symptoms,…
RT @BagaiDr: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact: average of 55.9+/- 25.5 symptoms,…
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact: average of 55.9+/- 25.5 symptoms, across average of 9.1 organ systems. most frequent symptoms after 6mth were fatigue,post-exertional malaise,cognitive dysfunction https://t.co/0vIRW4GzPX
RT @ygjumi: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/zMaLF38lHO
RT @ygjumi: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/zMaLF38lHO
RT @ygjumi: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/zMaLF38lHO
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/zMaLF38lHO
RT @emily_rj: @britandcelt Research since 2020 found common Long Covid cohorts in dysautonomia (another umbrella of dozens of conditions an…
Quellen: [1] https://t.co/Bs4zPen6Ga [2] https://t.co/NgF6X20lG5 [3] https://t.co/SJPLuZQdek [4] https://t.co/UlSZnUExfb [5] https://t.co/kDm3HdAB8E [6] https://t.co/nZPUcqYBVr [7] https://t.co/PgEE5d0mrA [8] https://t.co/hRyuwSsbVd [9] https://t.co/e6aoIzH49F
@britandcelt Research since 2020 found common Long Covid cohorts in dysautonomia (another umbrella of dozens of conditions and symptoms), POTS, MCAS, MECFS, Mito Disease. Covid causes connective tissue damage and triggers connective tissue disorders. This is LC too. https://t.co/t6sbucDOUj
RT @Tuathee: @ToeNegro @IAdam8722819003 @PiotrWitczak_ Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their…
@ToeNegro @IAdam8722819003 @PiotrWitczak_ Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact" - https://t.co/Csr9ZwmrhI "Long COVID: understanding the broader clinical spectrum" - https://t.co/gwIcoZdhLB "Post-acute COVID-19 syndrome" - https://t.co/sHV3NLudKI To tylko kilka :|
@amyboylanwrites Hannah Davis et al paper characterising Long Covid symptoms, found 89% of respondents had PEM https://t.co/sU0FxYESvx
@Hira35Yumi @itsukainuakani Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/orbbd5fvSY
RT @ErinSandersNP: 18/ And historic work by so many patients, including: How and Why Patients made Long COVID by @elisaperego78 & @felici…
RT @ErinSandersNP: 18/ And historic work by so many patients, including: How and Why Patients made Long COVID by @elisaperego78 & @felici…
RT @ErinSandersNP: 18/ And historic work by so many patients, including: How and Why Patients made Long COVID by @elisaperego78 & @felici…
RT @ErinSandersNP: 18/ And historic work by so many patients, including: How and Why Patients made Long COVID by @elisaperego78 & @felici…
RT @ErinSandersNP: 18/ And historic work by so many patients, including: How and Why Patients made Long COVID by @elisaperego78 & @felici…
RT @ErinSandersNP: 18/ And historic work by so many patients, including: How and Why Patients made Long COVID by @elisaperego78 & @felici…
18/ And historic work by so many patients, including: How and Why Patients made Long COVID by @elisaperego78 & @felicitycallard https://t.co/wdXlBK6TcI Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/DAk0WjHhwS
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/6pQQ9x6gU2
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. LongCovid study is important paper for 2022. https://t.co/tK3Xo6gMsg https://t.co/J9pTx5I6E8
RT @svillapol: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/zlgPjNIxmc "report…
RT @svillapol: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/zlgPjNIxmc "report…
RT @svillapol: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/zlgPjNIxmc "report…
RT @svillapol: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/zlgPjNIxmc "report…
RT @svillapol: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/zlgPjNIxmc "report…
RT @svillapol: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/zlgPjNIxmc "report…
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/zlgPjNIxmc "reported symptoms over time for those who recovered in less than 90 days, or otherwise experienced symptoms for more than 90 days" https://t.co/GduIylbS25
Characterizing long Covid in an international cohort: 7 months of symptoms and their impact by Davis et al (2021) https://t.co/3s9BN3er30
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/Z1oEynKEjR
(Links to studies on menstrual changes following COVID infection, since they wouldn’t all fit in one tweet!) 8/ https://t.co/6UoLiuY1g0 https://t.co/R0CcAfdqdF https://t.co/Z28gEJdS7Q
@AMannanBaig @SafetyFirst____ @ctrssierra @Naomi_D_Harvey @TheRealBiedz @EndzoneCone Very kind of you, but it isn’t yours. Luckily, it’s open access. https://t.co/6WKKTR08dH
COVID pone en la palestra al Sx disautonómico. Considerada como la nueva crisis de salud pública en UK, la disfunción autonómica post COVID urge de investigación que controle síntomas y reduzca secuelas. https://t.co/WRUWbYpTzF @ANCAM_MEXICO @siacprevent @acepuba @IniciativaPCM
RT @Katlanettle: @olga_basso @MeetJess Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https:/…
RT @patientled: We are thrilled to announce that after 13 months of work, our 3rd paper on #LongCOVID is officially peer-reviewed & publish…
@olga_basso @MeetJess Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/LEM4A1cVqt& Page 5: https://t.co/DLL4FCuPVM
RT @patientled: We are thrilled to announce that after 13 months of work, our 3rd paper on #LongCOVID is officially peer-reviewed & publish…
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact - eClinicalMedicine https://t.co/P52WE7byTy
RT @drannehuang: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. “Cognitive dysfunction or m…
RT @drannehuang: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. “Cognitive dysfunction or m…
RT @drannehuang: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. “Cognitive dysfunction or m…
RT @drannehuang: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. “Cognitive dysfunction or m…
RT @drannehuang: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. “Cognitive dysfunction or m…
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. “Cognitive dysfunction or memory issues were common across all age groups (~88%).” #LongCovid https://t.co/AoFW8qP6Aa via @ahandvanish https://t.co/fgF975poER https://t.co/nLzMbYNR0F
RT @KWollec: Quellen: Davis et al, 2021: (https://t.co/UlSZnUExfb) Twomey et al, 2022 (https://t.co/fGjobk9Q8V) Wright et al., 2022 (ht…
Quellen: Davis et al, 2021: (https://t.co/UlSZnUExfb) Twomey et al, 2022 (https://t.co/fGjobk9Q8V) Wright et al., 2022 (https://t.co/KFU1e3tvt4)
RT @patientled: We are thrilled to announce that after 13 months of work, our 3rd paper on #LongCOVID is officially peer-reviewed & publish…
@haldol Si le Covid long était aussi répandu que les propagandistes le disent et qu'il peut toucher tout le monde, je connaitrais des gens atteints, or j'en connais pas et on sait qu'on en guéris https://t.co/XVKaMR7m4z
RT @VivekSubbiah: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/yX0pjh4QUY
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact https://t.co/yX0pjh4QUY
RT @patientled: We are thrilled to announce that after 13 months of work, our 3rd paper on #LongCOVID is officially peer-reviewed & publish…
RT @patientled: We are thrilled to announce that after 13 months of work, our 3rd paper on #LongCOVID is officially peer-reviewed & publish…
RT @patientled: We are thrilled to announce that after 13 months of work, our 3rd paper on #LongCOVID is officially peer-reviewed & publish…
@Dr2NisreenAlwan Follow Dr David Putrino's work on #longcovid at Mt Sinai Also, this is really useful.https://t.co/VdUo7YMqSd
@Dr2NisreenAlwan https://t.co/VdUo7YMqSd
RT @patientled: We are thrilled to announce that after 13 months of work, our 3rd paper on #LongCOVID is officially peer-reviewed & publish…
RT @patientled: We are thrilled to announce that after 13 months of work, our 3rd paper on #LongCOVID is officially peer-reviewed & publish…
RT @patientled: We are thrilled to announce that after 13 months of work, our 3rd paper on #LongCOVID is officially peer-reviewed & publish…
RT @patientled: We are thrilled to announce that after 13 months of work, our 3rd paper on #LongCOVID is officially peer-reviewed & publish…
RT @AthenaAkrami: And here is the preprint: "Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact"…
RT @ATSCritCare: COVID-19 acquired disability and long-term cognitive outcomes are heterogeneous but not limited to older populations Refer…
RT @ATSCritCare: COVID-19 acquired disability and long-term cognitive outcomes are heterogeneous but not limited to older populations Refer…
RT @ATSCritCare: COVID-19 acquired disability and long-term cognitive outcomes are heterogeneous but not limited to older populations Refer…
COVID-19 acquired disability and long-term cognitive outcomes are heterogeneous but not limited to older populations References cited: https://t.co/CUaYijksLD https://t.co/TKOsOxy6x0 https://t.co/vkWt2xsQX9 https://t.co/jpbZp2fBhW https://t.co/R7BIZkj9Yz
The references to this slide: ▶️https://t.co/SLuwTTKCYp ▶️ https://t.co/HsOq7EzuGN ▶️ https://t.co/bdTU6TwmBq https://t.co/h3lj9vcYM0
@randomtalkwalk @COVIDnewsfast https://t.co/Dt4vYtVxUT
@F_I_Briest Tja, Sie finden Recruiting in Selbsthilfegruppen wohl absurd. Aber nichts ist so blöd, dass es nicht wirklich gemacht wird. Zitat: "We conducted an online survey of people with suspected and confirmed COVID-19, distributed via COVID-19 support groups" https://t.co/TFwFbkUxqi
@michaelcdeibert And this? (Not saying you’re wrong but WTF) https://t.co/qakls47R0l
@calirunnerdoc Start here: https://t.co/L4V2oP3Jxs
@KunstJonas (Why not look at @ahandvanish et al.'s study, for example, and selected the most theoretically important symptoms?) https://t.co/FQkleoqXzw
RT @mellziland: Dos 3.762 entrevistados em um estudo on-line de pessoas com sintomas persistentes após documentado ou suspeito de COVID-19,…
RT @mellziland: Dos 3.762 entrevistados em um estudo on-line de pessoas com sintomas persistentes após documentado ou suspeito de COVID-19,…
RT @mellziland: Dos 3.762 entrevistados em um estudo on-line de pessoas com sintomas persistentes após documentado ou suspeito de COVID-19,…
Dos 3.762 entrevistados em um estudo on-line de pessoas com sintomas persistentes após documentado ou suspeito de COVID-19, muitos apresentavam sintomas contínuos até 7 meses após a infecção inicial, incluindo síndromes neuropsiquiátricas proeminentes https://t.co/APJEUNCyG7
@MagChange_73 @HouleEvelyne Perso, je ne souhaite la #CovidLongue à personne. Libre à vous de choisir vos risques, pour vous et votre entourage. L'incidence reste à préciser et varie selon les études. Même avec les % conservateurs, c'est énorme. Pour le reste
RT @touretteturgis: Sources: https://t.co/53khFIG5Ee https://t.co/YooSTQHqrR
Sources: https://t.co/53khFIG5Ee https://t.co/YooSTQHqrR
@Chat_Sidere https://t.co/Hgd6mRvmeZ https://t.co/7h9QsK7GWz https://t.co/a6ItvMBLyO https://t.co/D56E1w0iLB https://t.co/2eEsXWjCQq Bonne lecture. Et j'en ai d'autres
@CurbYT333 @Gdavey2 @amaechi1234 @BenCrellin https://t.co/OSCb1yFfcB
RT @Elisa34088370: @covid19cl @sochimfyr2018 @colkine Gracias por visibilizar el #LongCovid y las dificultades para quienes fuimos enfermos…
@covidpersistecl https://t.co/QvS5UVsPRu Caracterización completa publicado en sciencedirect. Que no digan q no existe ;) #LongCovid
@covid19cl @sochimfyr2018 @colkine Gracias por visibilizar el #LongCovid y las dificultades para quienes fuimos enfermos "leves", pero llevamos meses con problemas mayores que los vividos durante la infección. @patientled https://t.co/QvS5UVsPRu
RT @sandralopezleon:
RT @sandralopezleon:
Another interesting study on Long COVID https://t.co/JTOg4rizLs
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
Identifican 203 síntomas del Covid persistente https://t.co/KEEMhORvqJ
https://t.co/cMDyvPhHLy
"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact" Davis HE et al. EClinicalMedicine. 2021-07-15. https://t.co/pfzcWIrPBa Patient-Led Research Collaborative a total of 3,762 people quizzed across 56 countries
als 200 verschiedene Beschwerden an, die bei den meisten auch nach 6 Monaten noch bestanden. Mehr als die Hälfte der Betroffenen waren nach den in EClinicalMedicine (2021; DOI: 10.1016/j.eclinm.2021.101019) veröffentlichten Ergebnissen nicht oder nur eingeschränkt arbeitsfähig.
CE